Taho Pharmaceuticals Ltd. (TPEX:6467)
Taiwan · Delayed Price · Currency is TWD 130.50
+1.00 (0.77%)
At close: Jun 18, 2026
Taho Pharmaceuticals Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2017 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '17 Dec 31, 2017 |
Net Income | -232.53 | -214.4 | -167.44 | -120.68 | -66.3 | -137.14 |
Depreciation & Amortization | 8.73 | 8.66 | 6.99 | 7.75 | 8.94 | 15.76 |
Other Amortization | - | - | - | - | - | 0.58 |
Loss (Gain) From Sale of Assets | - | - | - | - | - | 5.78 |
Stock-Based Compensation | 20.23 | 12.65 | 0.04 | 0.35 | 0.52 | -0.15 |
Provision & Write-off of Bad Debts | - | - | - | -2.78 | 1.39 | - |
Other Operating Activities | -0.13 | 0.07 | -0.44 | -0.14 | 0.47 | 0.02 |
Change in Accounts Receivable | 2.28 | -0.16 | - | 2.78 | - | 8.36 |
Change in Inventory | - | - | - | - | - | 4.52 |
Change in Accounts Payable | - | - | - | - | - | -0.34 |
Change in Unearned Revenue | - | -0.71 | 0.71 | -0.19 | -1.67 | - |
Change in Income Taxes | - | - | - | - | - | -0.03 |
Change in Other Net Operating Assets | 6.06 | -9.85 | 3.23 | 8.7 | -6.13 | -33.82 |
Operating Cash Flow | -195.36 | -203.73 | -156.91 | -104.22 | -62.78 | -136.46 |
Capital Expenditures | -4.93 | -5.41 | -8.82 | -2.89 | -0.83 | -1.97 |
Sale of Property, Plant & Equipment | - | - | - | - | - | 0.14 |
Sale (Purchase) of Intangibles | -0.6 | -0.9 | - | - | - | - |
Investment in Securities | 100 | 200 | -179.95 | -46.07 | 10 | - |
Other Investing Activities | -0.01 | 0.09 | -0.1 | -0.09 | - | -0.16 |
Investing Cash Flow | 94.45 | 193.78 | -188.86 | -49.04 | 9.17 | -1.99 |
Short-Term Debt Issued | - | - | - | - | - | 0.4 |
Total Debt Issued | - | - | - | - | - | 0.4 |
Long-Term Debt Repaid | - | -5.34 | -4.97 | -4.31 | -4.92 | -0.02 |
Net Debt Issued (Repaid) | -5.39 | -5.34 | -4.97 | -4.31 | -4.92 | 0.38 |
Issuance of Common Stock | 107.72 | 109.4 | 476.91 | 234.98 | 93.6 | - |
Financing Cash Flow | 102.33 | 104.06 | 439.94 | 230.67 | 88.68 | 0.38 |
Foreign Exchange Rate Adjustments | - | - | - | - | - | -2.16 |
Net Cash Flow | 1.42 | 94.11 | 94.16 | 77.41 | 35.07 | -140.23 |
Free Cash Flow | -200.29 | -209.14 | -165.73 | -107.1 | -63.61 | -138.44 |
Free Cash Flow Margin | -3694.78% | -2486.80% | - | -10047.00% | -1000.49% | -1116.35% |
Free Cash Flow Per Share | -3.87 | -4.06 | -3.65 | -2.76 | -1.77 | -2.65 |
Cash Interest Paid | 0.48 | 0.53 | 0.9 | 1.33 | 0.05 | 0.03 |
Cash Income Tax Paid | 0.2 | 0.2 | 0.25 | 0.07 | -0.01 | - |
Levered Free Cash Flow | - | -130.75 | -135.21 | -61.65 | - | -29.49 |
Unlevered Free Cash Flow | - | -130.42 | -134.64 | -60.78 | - | -29.47 |
Change in Working Capital | 8.34 | -10.71 | 3.94 | 11.29 | -7.8 | -21.31 |